CAMPBELL'S Co (CPB) stock
Close on Nov 17, 2026Market cap $7.03BP/E 18.0Yield 6.62%
Earnings
Campbell'S's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Campbell'S's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q1 FY2027ended Nov 2, 2026 | Dec 8, 2026Expected | – | – | – | – | – |
| Q4 FY2026ended Aug 2, 2026 | Sep 3, 2026before the open | $2.10B | -8.7% | -$0.23 | $0.39 | Release |
| Q3 FY2026ended May 3, 2026 | Jun 8, 2026before the open | $2.40B | -4.0% | – | – | Release |
| Q2 FY2026ended Feb 1, 2026 | Mar 11, 2026before the open | $2.60B | -3.7% | – | – | Release |
| Q1 FY2026ended Nov 2, 2025 | Dec 9, 2025before the open | $2.70B | -2.6% | $0.65 | $0.77 | Release |
| Q4 FY2025ended Aug 3, 2025 | Sep 3, 2025before the open | $2.30B | 0.0% | $0.48 | $0.62 | Release |
| Q3 FY2025ended Apr 27, 2025 | Jun 2, 2025before the open | $2.50B | +4.2% | $0.22 | $0.73 | Release |
| Q2 FY2025ended Jan 26, 2025 | Mar 5, 2025before the open | $2.70B | +8.0% | $0.58 | $0.74 | Release |
| Q1 FY2025ended Oct 27, 2024 | Dec 3, 2024after the close | $2.77B | +10.9% | – | – | Release |
| Q4 FY2024ended Jul 28, 2024 | Aug 29, 2024before the open | $2.30B | +9.5% | -$0.01 | $0.63 | Release |
| Q3 FY2024ended Apr 28, 2024 | Jun 5, 2024before the open | $2.40B | +9.1% | $0.44 | $0.75 | Release |
| Q2 FY2024ended Jan 28, 2024 | Mar 6, 2024before the open | $2.50B | 0.0% | $0.68 | $0.80 | Release |
| Q1 FY2024ended Oct 29, 2023 | Dec 6, 2023before the open | $2.50B | -2.9% | $0.78 | $0.91 | Release |
| Q4 FY2023ended Jul 30, 2023 | Aug 31, 2023before the open | $2.10B | +5.0% | $0.57 | $0.50 | Release |
| Q3 FY2023ended Apr 30, 2023 | Jun 7, 2023before the open | $2.20B | +3.3% | $0.53 | $0.68 | Release |
| Q2 FY2023ended Jan 29, 2023 | Mar 8, 2023before the open | $2.50B | +13.1% | $0.77 | $0.80 | Release |
| Q1 FY2023ended Oct 30, 2022 | Dec 7, 2022before the open | $2.58B | +15.0% | $0.99 | $1.02 | Release |
| Q4 FY2022ended Jul 31, 2022 | Sep 1, 2022before the open | $2.00B | – | $0.32 | $0.56 | Release |
| Q3 FY2022ended May 1, 2022 | Jun 8, 2022before the open | $2.13B | – | $0.62 | $0.70 | Release |
| Q2 FY2022ended Jan 30, 2022 | Mar 9, 2022before the open | $2.21B | – | $0.70 | $0.69 | Release |
| Q1 FY2022ended Oct 31, 2021 | Dec 8, 2021before the open | $2.24B | – | $0.86 | $0.89 | Release |
| Q4 FY2021ended Aug 1, 2021 | Sep 1, 2021before the open | – | – | – | – | Filing |
| Q3 FY2021ended May 2, 2021 | Jun 9, 2021before the open | – | – | – | – | Filing |
| Q2 FY2021ended Jan 31, 2021 | Mar 10, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Nov 1, 2020 | Dec 9, 2020before the open | – | – | – | – | Release |
| Q4 FY2020ended Aug 2, 2020 | Sep 3, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Campbell'S's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted EPS*non-GAAP | FY2027 | $1.65 – $1.80 | – | New | Sep 3, 2026 |
Guidance vs results
The last range Campbell'S gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Revenue growth | -2% – 0% | -4.6%Σ4Q | Below range |
Guidance history
Every forecast Campbell'S put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Sep 3, 2026 | Adjusted EPS* | FY2027 | $1.65 – $1.80 | New |
| Mar 11, 2026 | Adjusted EPS | FY2026 | $2.15 – $2.25 | Lowered |
| Dec 9, 2025 | Adjusted EPS | FY2026 | -18% – -12% | Reaffirmed |
| Dec 9, 2025 | Adjusted EPS | FY2026 | $2.40 – $2.55 | Reaffirmed |
| Dec 9, 2025 | Adjusted EBIT | FY2026 | -13% – -9% | Reaffirmed |
| Dec 9, 2025 | Organic Net Sales | FY2026 | -1% – +1% | Reaffirmed |
| Sep 3, 2025 | Capital expenditures | FY2026 | 4% | New |
| Sep 3, 2025 | adjusted EPS | FY2026 | -18% – -12% | New |
| Sep 3, 2025 | Adjusted EPS | FY2026 | $2.40 – $2.55 | New |
| Sep 3, 2025 | Adjusted EBIT | FY2026 | -13% – -9% | New |
| Sep 3, 2025 | Diluted share count | FY2026 | 300 | New |
| Sep 3, 2025 | Adjusted effective tax rate | FY2026 | 24% | New |
| Sep 3, 2025 | Enterprise cost savings | FY2026 | $70.00M | New |
| Sep 3, 2025 | Adjusted interest expense | FY2026 | $320.00M – $325.00M | New |
| Sep 3, 2025 | Net Sales | FY2026 | -2% – 0% | New |
| Sep 3, 2025 | Organic Net Sales | FY2026 | -1% – +1% | New |
| Jun 2, 2025 | Adjusted EPS | FY2025 | $2.95 – $3.05 | New |
| Mar 5, 2025 | Adjusted EPS | FY2025 | $2.95 – $3.05 | Lowered |
| Mar 5, 2025 | Adjusted EBIT growth | FY2025 | +3% – +5% | Lowered |
| Mar 5, 2025 | cost savings | FY2025 | $120.00M | New |
| Mar 5, 2025 | Net interest expense | FY2025 | $325.00M – $330.00M | Raised |
| Mar 5, 2025 | Net sales growth | FY2025 | +6% – +8% | New |
| Dec 3, 2024 | Adjusted EPS | FY2025 | $3.12 – $3.22 | Reaffirmed |
| Aug 29, 2024 | Adjusted EPS | FY2025 | $3.12 – $3.22 | New |
| Aug 29, 2024 | Adjusted EBIT | FY2025 | +9% – +11% | New |
| Aug 29, 2024 | Net Sales | FY2025 | +9% – +11% | New |
| Aug 29, 2024 | Organic Net Sales | FY2025 | 0% – +2% | New |
| Jun 5, 2024 | adjusted earnings per share | FY2024 | $3.07 – $3.10 | Lowered |
| Jun 5, 2024 | adjusted EBIT growth | FY2024 | +6.5% – +7% | Raised |
| Jun 5, 2024 | reported net sales growth | FY2024 | +3% – +4% | Raised |
| Jun 5, 2024 | Organic net sales growth | FY2024 | -1% – 0% | Lowered |
| Mar 6, 2024 | Adjusted EPS | FY2024 | $3.09 – $3.15 | Reaffirmed |
| Mar 6, 2024 | Adjusted EBIT | FY2024 | +3% – +5% | Reaffirmed |
| Mar 6, 2024 | Net Sales | FY2024 | -0.5% – +1.5% | Reaffirmed |
| Mar 6, 2024 | Organic Net Sales | FY2024 | 0% – +2% | Reaffirmed |
| Dec 6, 2023 | Adjusted EPS | FY2024 | $3.09 – $3.15 | Reaffirmed |
| Dec 6, 2023 | Adjusted EBIT | FY2024 | +3% – +5% | Reaffirmed |
| Dec 6, 2023 | Net Sales | FY2024 | -0.5% – +1.5% | Reaffirmed |
| Dec 6, 2023 | Organic Net Sales | FY2024 | 0% – +2% | Reaffirmed |
| Aug 31, 2023 | Adjusted EPS | FY2024 | $3.09 – $3.15 | New |
| Aug 31, 2023 | Adjusted EBIT | FY2024 | +3% – +5% | New |
| Aug 31, 2023 | Net Sales | FY2024 | -0.5% – +1.5% | New |
| Aug 31, 2023 | Organic Net Sales | FY2024 | 0% – +2% | New |
| Jun 7, 2023 | Adjusted EPS | FY2023 | $2.95 – $3.00 | Reaffirmed |
| Jun 7, 2023 | Adjusted EBIT | FY2023 | +4.5% – +6.5% | Reaffirmed |
| Jun 7, 2023 | Net Sales | FY2023 | +8.5% – +10% | Reaffirmed |
| Jun 7, 2023 | Organic Net Sales | FY2023 | +8.5% – +10% | Reaffirmed |
| Mar 8, 2023 | Adjusted EPS | FY2023 | $2.95 – $3.00 | Raised |
| Mar 8, 2023 | Adjusted EBIT | FY2023 | +4.5% – +6.5% | Raised |
| Mar 8, 2023 | Net Sales | FY2023 | +8.5% – +10% | Raised |
| Mar 8, 2023 | Organic Net Sales | FY2023 | +8.5% – +10% | Raised |
| Dec 7, 2022 | Adjusted EPS | FY2023 | $2.90 – $3.00 | Raised |
| Dec 7, 2022 | Adjusted EBIT | FY2023 | +2.5% – +6.5% | Raised |
| Dec 7, 2022 | Net Sales | FY2023 | +7% – +9% | Raised |
| Dec 7, 2022 | Organic Net Sales | FY2023 | +7% – +9% | Raised |
| Sep 1, 2022 | Adjusted EPS | FY2023 | $2.85 – $2.95 | New |
| Sep 1, 2022 | Adjusted EBIT | FY2023 | +1% – +5% | New |
| Sep 1, 2022 | Net Sales | FY2023 | +4% – +6% | New |
| Sep 1, 2022 | Organic Net Sales | FY2023 | +4% – +6% | New |
| Jun 8, 2022 | Adjusted EPS | FY2022 | $2.75 – $2.85 | Reaffirmed |
| Jun 8, 2022 | Adjusted EBIT | FY2022 | -4.5% – -1.5% | Reaffirmed |
| Jun 8, 2022 | Net Sales | FY2022 | 0% – +1% | Raised |
| Jun 8, 2022 | Organic Net Sales | FY2022 | +1% – +2% | Raised |
| Mar 9, 2022 | Adjusted EPS | FY2022 | $2.75 – $2.85 | Reaffirmed |
| Mar 9, 2022 | Adjusted EBIT | FY2022 | -4.5% – -1.5% | Reaffirmed |
| Mar 9, 2022 | Net Sales | FY2022 | -2% – 0% | Reaffirmed |
| Mar 9, 2022 | Organic Net Sales | FY2022 | -1% – +1% | Reaffirmed |
| Dec 8, 2021 | Adjusted EPS | FY2022 | $2.75 – $2.85 | New |
| Dec 8, 2021 | Adjusted EBIT | FY2022 | -4.5% – -1.5% | New |
| Dec 8, 2021 | Net Sales | FY2022 | -2% – 0% | New |
| Dec 8, 2021 | Organic Net Sales | FY2022 | -1% – +1% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Campbell'S filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Update
See a number that looks wrong?